Cardiogenesis (Irvine, California), a developer of surgical products for cardiac revascularization, reported a scientific presentation that describes the use of the Phoenix delivery system combining transmyocardial revascularization (TMR) with autologous bone marrow derived stem cells.

At press time: Cardiogenesis reports on TMR/stem cell combination

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR